​Drug Study

Name of Student: Justine L. Bautista Level: 2 Section: B Group No: 1 Area of Assignment: Pediatrics Ward Date Submitted: 05/16/2023
Drug, Dosage, Classification Mechanism of Specific Effects Contraindications and Nursing Responsibilities
Frequency, and Action Indication Drug-to-Drug
Route Interactions
Date ordered: Pharmacological Needed for the Prevention and Side Effects: Contraindications Before:
05/15/2023 : adequate treatment of CNS: confusion Renal disease (severe), severe 1. Check the doctor’s order
Electrolyte transmission of hypokalemia CV: hemolytic disease, Addison’s 2. Check the medication
Generic: supplement nerve impulses Bradycardia, disease, hyperkalemia, acute for expiration
Potassium chloride and cardiac cardiac dehydration, extensive tissue 3. Assess the patient’s
contraction, renal depression, breakdown history of allergies
Trade name: function, dysrhythmias, 4. Obtain a baseline ECG
K-Tab intracellular ion arrest; peaking T Drug-to-Drug to assess for patient’s
maintenance waves, lowered Interactions cardiac rhythm
Functional: R, depressed Increase: hyperkalemia — 5. Review the patient’s
Dosage: Electrolyte, RST, prolonged potassium phosphate IV; medication profile for
750 mg/tab mineral P-R interval, products containing calcium or potential drug interactions
replacement References: widened QRS magnesium; potassium-sparing
Frequency: Skidmore-Roth, complex diuretic or other potassium During:
TID L. (2021). GI: Nausea, products; ACE inhibitors 1. Verify the patient’s
Mosby’s 2021 vomiting, identity
Route: nursing drug cramps, pain, References: 2. Administer orally as
PO reference (34th diarrhea, Skidmore-Roth, L. (2021). indicated
ed.). Elsevier ulceration of Mosby’s 2021 nursing drug 3. Observe sterility in
small bowel reference (34th ed.). Elsevier administering the
GU: Oliguria medication
INTEG: cold 4. Continuously monitor
extremities, rash the patient during
administration for any
signs of adverse reactions
Adverse
Effects: After:
Abnormal ECG; 1. Continuously monitor
irregular pulse; the patient’s serum
muscle potassium level
weakness; 2. Assess the patient for
numbness; any signs and symptoms of
tingling electrolyte imbalances
3. Provide education to the
caregiver on the
importance of adhering to
References: medication regimen and
Skidmore-Roth, dietary restrictions
L. (2021). 4. Document medication
Mosby’s 2021 administration in the
nursing drug patient’s chart
reference (34th
ed.). Elsevier References:
Wilson, B., Shannon, M. &
Shield, K. (2019).
Pearson’s nurse’s drug
guide 2020. Pearson
 DRUG STUDY #2

Name of Student: Justine L. Bautista Level: 2 Section: B Group No: 1 Area of Assignment: Pediatrics Ward Date Submitted: 05/16/2023
Drug, Dosage, Classification Mechanism of Specific Effects Contraindications and Nursing Responsibilities
Frequency, and Action Indication Drug-to-Drug
Route Interactions
Date ordered: Pharmacological: May block pain Mild to Side Effects: Contraindications Before:
05/15/2023 Analgesic impulses moderate pain CNS: agitation, Hypersensitivity to this product, 1. Check the doctor’s order
peripherally that or fever, headache, phenacetin, aspartame, saccharin, 2. Check the medication
Generic: occur in response arthralgia, anxiety tartrazine for expiration
Paracetamol to inhibition of dental pain, CV: hyper- and 3. Assess the patient’s
prostaglandin dysmenorrhea, hypotension Drug-to-Drug medical history for any
Trade name: synthesis; does headache, RESP: dyspnea, Interactions known allergies
Biogesic Functional: not possess myalgia, atelectasis Increase: renal adverse reactions 4. Review the patient’s
Nonopioid antiinflammatory osteoarthritis GI: Nausea, – NSAIDs, salicylates; consider medication profile for
analgesic, properties; vomiting, lower dose potential drug interactions
Dosage: antipyretic antipyretic action abdominal pain Increase: methemoglobinemia
250 mg/5 ml susp. results from GU: Renal –nitric oxide, prilocaine; avoid During:
inhibition of failure concurrent use 1. Verify the patient’s
Frequency: prostaglandins in INTEG: rash, Increase: hypoprothrombinemia identity
PRN the CNS urticaria, inj site –warfarin, long-term use, high 2. Administer orally as
pain doses of acetaminophen indicated
Route: Decrease: absorption–colestipol, 3. Observe sterility in
PO References: Adverse cholestyramine administering the
Skidmore-Roth, Effects: medication
L. (2021). Fever with or References: 4. Continuously monitor
Mosby’s 2021 without chills; the patient during
nursing drug pain in the lower
reference (34th back; skin rash; Skidmore-Roth, L. (2021). administration for any
ed.). Elsevier hives; itching; Mosby’s 2021 nursing drug signs of adverse reactions
sore throat; reference (34th ed.). Elsevier
oliguria After:
1. Continuously monitor
the patient's pain level and
References: response to paracetamol.
Skidmore-Roth, 2. Regularly monitor the
L. (2021). patient’s temperature to
Mosby’s 2021 assess for effectiveness
nursing drug 3. Provide education to the
reference (34th caregiver about the proper
ed.). Elsevier use of paracetamol
4. Document medication
administration in the
patient’s chart

References:
Wilson, B., Shannon, M. &
Shield, K. (2019).
Pearson’s nurse’s drug
guide 2020. Pearson
 DRUG STUDY #3

Name of Student: Justine L. Bautista Level: 2 Section: B Group No: 1 Area of Assignment: Pediatrics Ward Date Submitted: 05/16/2023
Drug, Dosage, Classification Mechanism of Specific Effects Contraindications and Nursing Responsibilities
Frequency, and Action Indication Drug-to-Drug
Route Interactions
Date ordered: Pharmacological: Vitamin C is To help Side Effects: Contraindications Before:
05/15/2023 Antioxidants fundamental in strengthen the CNS: fainting, Hypersensitivity to this product,
1. Check the doctor’s order
the synthesis of immune headache hypercalcemia, 2. Check the medication
Generic: collagen and system GI: nausea, hypermagnesemia for expiration
Ascorbic acid intracellular vomiting, 3. Assess the patient’s
materials. Zinc is diarrhea Drug-to-Drug medical history for any
Trade name: necessary for the Interactions known allergies
Ceelin Functional: proper Adverse Do not take with milk and other 4. Obtain baseline vital
Vitamin C and functioning of Effects: dairy products or antacids. signs
zinc supplement over 200 GI: GI upset, Calcium may make it harder for
Dosage: metalloenzymes diarrhea, your body to absorb certain During:
100 mg/ 5 ml syr. including vomiting minerals 1. Verify the patient’s
carbonic HEMA: identity
Frequency: anhydrase 1. hemolysis References: 2. Administer medications
OD Skidmore-Roth, L. (2021). orally as indicated
Mosby’s 2021 nursing drug 3. Observe sterility in
Route: References: References: reference (34th ed.). Elsevier administering the
PO Kash, A.M. Kash, A.M. medication
(2014). Nursing (2014). Nursing 4. Inform patient that
drug guide. drug guide. medications should be
Lippincott. Lippincott. taken between meals for
Wolters Kluwer. Wolters Kluwer. best absorption
After:
1. Assess hypersensitivity
to drug
2. Advise patient’s
guardian to inform the
physician if adverse effects
occur
3. Monitor patient’s V/S
and I&O
4. Document medication
administration in the
patient’s chart

References:
Wilson, B., Shannon, M. &
Shield, K. (2019).
Pearson’s nurse’s drug
guide 2020. Pearson
 Nursing Care Plan

Name of Student: Justine L. Bautista Level: 2 Section: B Group No: 1 Area of Assignment: Pediatrics Ward Date Submitted: ______________
Nursing theorist: Sister Callista Roy
Theory: Adaptation Model
Data Nursing Scientific Basis Objective/s of Intervention Rationale Evaluation
Diagnosis Care
Subjective: Impaired Definition of nursing Long term: Independent: Actual:
“Nakabantay ko physical diagnosis: After 2 days of 1. Monitor for signs and Hypokalemia can be The objective of
nga sigi ni siyag mobility related Limitation in independent, nursing symptoms of life-threatening. care was:
duko,” as to muscle purposeful physical movement intervention, the hypokalemia Careful assessment resolved
verbalized by the weakness and of the body or of one or more client will be able for its early partially-
grandmother periodic extremities to maintain serum presence is needed resolved
paralysis potassium and not resolved
Objective: Pathophysiologic basis: serum sodium 2. Monitor ECG To detect for any
- lower extremity Mutations in the CACNA1S levels within continuously abnormalities in the
weakness noted or SCN4A gene alter the usual normal range patient’s heart
- neck weakness structure and function of activity
observed calcium or sodium channels. Short term:
The altered channels are After 1 hour of 3. Strict monitoring of This is essential
Labs: "leaky," allowing ions to flow health teaching, intake and output because 40 mEq of
- Serum slowly but continually into the client will be potassium is lost for
Potassium (K) = muscle cells, which reduces able to: every liter of urine
1.8 (Low) the ability of skeletal muscles - Identify
- Serum Sodium to contract. Because muscle measures to 4. Assist client in Potassium rich
(Na) = 131 contraction is needed for prevent selecting foods rich in foods in diet helps
(Low) movement, a disruption in hypokalemia potassium such as banana maintain potassium
normal ion transport leads to balance
episodes of severe muscle Dependent:
weakness or paralysis. 1. Administer To decrease the
medications as prescribed symptoms of
Rationale hypokalemia
This condition is inherited in
autosomal dominant pattern Collaborative:
which means one copy of the 1. Monitor serum Evaluates
altered gene in each cell is potassium levels effectiveness of
sufficient to cause the therapy
disorder.

References:
Doenges, M., Moorhouse, M.
& Murr, A. (2019). Nurse’s
pocket guide: Diagnoses,
prioritized intervention, and
rationales (15th ed.). F.A.
Davis
References:
RNspeak. (2018).
Hypokalemia nursing
care plan. Retrieved from
https://rnspeak.com/hypo
kalemia-nursing-care-pla
n/

Hypokalemic periodic
paralysis. (2020). Medline
Plus. Retrieved from
https://medlineplus.gov/geneti
cs/condition/hypokalemic-peri
odic-paralysis/#inheritance